Screen Shot 2020-04-02 at 1.46.44 PM.png

Proudly presented by:

Screen Shot 2020-04-02 at 1.48.28 PM.png

2020 Winners Announced!

Screen Shot 2020-06-16 at 12.08.40 PM.png
 

In light of the global spread of COVID-19, the logistics of everyday life have changed drastically for so many. During these difficult times, there is a desire to return to "normal." It is important to remember, however, that for many communities "normal" was not yet equal or equitable. As we come out of this pandemic — and we will — we will have the unique opportunity to create a world that is more diverse, more equitable and more inclusive. 

To accelerate this change, the Roddenberry Foundation in partnership with A Day of Unreasonable Conversation will grant ten $10K Roddenberry Impact Awards to ideas and projects that are making strides in one of the following areas: Inclusive Futures, Authentic Content Creation, and Increased Representation. Roddenberry Impact Awards will be granted to television content creators who are committed to - and have innovative ideas and approaches for - reimagining the processes for writing and telling stories that are more equitable and inclusive.

The awards were originally slated to be announced at A Day of Unreasonable Conversation in March 2020, but the event was postponed due to the global spread of the Coronavirus (COVID-19).

The Roddenberry Impact Awards submissions will be judged by industry leaders who have driven significant change through their own storytelling and leadership in the business. The esteemed panel of judges includes Daniel Dae Kim, Gloria Calderón Kellett, Sara Gilbert, Jaime Dávila, Sameer Gardezi, and Tanya Saracho.

The Award application period is closed for 2020.

The awards were open for submission to all Writers Guild of America West, Writers Guild of America, East, Producers Guild of America, Directors Guild of America, and SAG-AFTRA members in active status. 

A Day of Unreasonable Conversation will return in 2021.

For daily updates and recommended steps to prevent illness, please visit the CDC website: cdc.gov